LivOnyx Inc.

[Available On-Demand] ・ Click video to start playback; Join chat Q&A below video
Search General Info
Did you know that 1 out of 25 patients that go into US acute care hospitals come out with an infection they didn’t have to start with - and those infections could largely be prevented with better hand hygiene? Rejecting the hand hygiene status quo, LivOnyx is developing a novel, fully automated device and antiseptic, that will be where you need it at every patient’s bedside, targets today’s toughest clinical pathogens including SARS-CoV-2 (the virus that causes COVID-19), MRSA, Clostridioides difficile (Cdiff) spores and more, allowing you to sanitize and dry hands the right way, every time in 3-5 seconds.
Speaker
photo
President & Co-Founder
LivOnyx Inc.